June 6, 2007 — Results from an MRI substudy of the ongoing FRALYSE randomized trial, although not statistically significant for most end points, show positive trends that infusion of tissue ...
A new report details the case of a patient on the new experimental Alzheimer's drug, lecanemab, who died after experiencing numerous acute intracerebral hemorrhages during treatment with tissue ...
Thrombolytic therapy for ischemic stroke with tissue plasminogen activator (tPA) increases the risk of brain hemorrhage. In a Nature Medicine paper, Cheng et al. report that, in rodents, activated ...
PHOENIX -- Adjunctive thrombolysis with either argatroban or eptifibatide for acute ischemic stroke did not boost efficacy and contributed to risk, the MOST trial showed. When given after starting ...
Despite probable higher rates of recanalization with endovascular therapies, limited evidence exists to support the clinical benefits in patients with stroke who are unresponsive to standard ...
Giving the clot-busting medication alteplase at the site of a blocked brain artery after blood clot removal may increase the number of patients who fully recover, according to preliminary ...
BERWYN, Pa.--(BUSINESS WIRE)--AscellaHealth, a national specialty pharmacy benefit manager (SPBM) serving commercial, Medicare and Medicaid segments, is collaborating with Group & Pension ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results